+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Japan IVD Tissue Diagnostics Market (By Segment - Pre-Analytical Processing, H&E Staining, Special Staining, IHC Staining, ISH Staining, Digital Pathology, Workflow Solutions), Company Share Analysis, Market Dynamics and Recent Developments - Forecast to 2030

  • PDF Icon

    Report

  • 87 Pages
  • June 2025
  • Region: Japan
  • iGATE Research
  • ID: 6093640

The Japan tissue diagnostics market is predicted to reach US$ 234 Million by 2030, from around US$ 150 Million in 2024. Japan is one of the leading markets for tissue diagnostics in the Asia-Pacific region. The rising incidence of chronic conditions such as cancer, diabetes, and cardiovascular diseases is driving the need for more advanced tissue diagnostic technologies in the region. Moreover, the population of Japan is aging rapidly with around 30% of the Japanese population aged 65 and over, a demographic that is more vulnerable to chronic conditions. Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Additionally, physicians in Japan are rapidly shifting from traditional testing processes to tissue-based diagnostic techniques, as these tests shorten turnaround times when compared to traditional approaches, thereby propelling the market growth. 

Recent Developments

  • In January 2024, bioMerieux announced the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.
  • In October 2023, Sysmex and Fujirebio entered into a business collaboration agreement in the field of immunoassay, in a bid to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay.
  • In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.
  • In April 2023, bioMérieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System. The rapid AST system VITEK REVEAL is already available on-market under CE-IVDD (assay panel) and IVDR (instrument) designation across Europe.

By Segment: Japan IVD Tissue Diagnostics Market - Key Takeaways

  • Immunohistochemistry is the largest segment of the tissue diagnostics market. The increasing prevalence of cancer is likely to push the growth of immunohistochemistry (IHC) market over the forecast period. The recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are further propelling the market growth. 
  • Pre-analytical processing is the second largest segment of the tissue diagnostics market. With the advancements in automation technology, more diagnostic laboratories and healthcare settings are likely to adopt automated pre-analytical systems to improve efficiency and reduce errors, thereby driving the market growth. 
  • Sakura Finetek Japan is the major player in the pre-analytical processing market. Their products are widely used in histopathology, cytology, and other diagnostic processes.
  • Hematoxylin and Eosin (H&E) staining is one of the most common and essential staining techniques used in the preparation of tissue samples for microscopic examination, particularly in histology, pathology, and oncology. Muto Pure Chemicals is a prominent player in the Japanese H&E manual staining reagents market.
  • ISH is a powerful molecular biology technique used to visualize and locate specific nucleic acid sequences within cells or tissues. The continuous technological advancement in the field of in-vitro diagnostics is a significant driving factors for the in-situ hybridization market. For instance, automation of ISH workflows and the availability of digital imaging systems have made the technique more efficient, reducing hands-on time and improving data analysis. 
  • Abbott dominates the Japan ISH staining market, as their extensive portfolio enables the company to cater to various diagnostic needs in molecular pathology and oncology.
  • Digital pathology is one of the fastest growing segments of the Japan tissue diagnostics market. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses.
  • Workflow solutions captured least share of the Japan tissue diagnostics market.
  • The report provides a comprehensive assessment of the fast-evolving, high-growth Japan Tissue Diagnostics Market. 

This 87 Pages report with 44 Figures has been analyzed from 6 viewpoints:

1) Japan IVD Tissue Diagnostics Market and Forecast (2021 - 2030)
2) Japan IVD Tissue Diagnostics Market Share and Forecast (2021 - 2030) 
3) By Segment - Japan IVD Tissue Diagnostics Market & Forecast (2021 - 2030) 
4) Japan IVD Tissue Diagnostics Market & Forecast - Company Profiles 
5) Japan IVD Market - Recent Developments 
6) Japan IVD Tissue Diagnostics Market - Market Dynamics

By Segment: Japan IVD Tissue Diagnostics Market and Forecast

1. Pre-Analytical Processing 
2. H&E Staining 
3. Special Staining 
4. IHC Staining
5. ISH Staining 
6. Digital Pathology
7. Workflow Solutions 

Japan IVD Tissue Diagnostics Market - Company Analysis

1. Roche 
2. Abbott Laboratories
3. Sakura Finetek Japan Co., Ltd.
4. Leica Biosystems 
5. Agilent Dako 
6. Nichirei Biosciences Inc.
7. Epredia 

Data Sources

The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and in-house analysis by a dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interviews, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Introduction
1.1 Industry Definition and Research Scope
1.2 Research Methodology

2. Executive Summary3. Japan IVD - Tissue Diagnostics (TDx) Market and Forecast (2021 - 2030)4. By Segment - Japan IVD Tissue Diagnostics (TDx) Market Share and Forecast (2021 - 2030)
5. By Segment - Japan IVD Tissue Diagnostics (TDx) Market and Forecast (2021 - 2030)
5.1 Japan IVD Tissue Diagnostics (TDx) - Pre-Analytical Processing Market and Forecast
5.1.1 Japan Pre-Analytical Processing - Instruments Market and Forecast
5.1.2 Japan Pre-Analytical Processing - Consumables Market and Forecast
5.1.3 Japan Pre-Analytical Processing Market - Company Share
5.2 Japan IVD Tissue Diagnostics (TDx) - H&E Staining Market and Forecast
5.2.1 Japan H&E Staining - Instruments Market and Forecast
5.2.2 Japan H&E Staining Instruments Market - Company Share
5.2.3 Japan H&E Staining - Reagents Market and Forecast
5.2.4 Japan H&E - Manual Staining Reagents Market and Forecast
5.2.5 Japan H&E Manual Staining Reagents Market - Company Share
5.2.6 Japan H&E Staining - Automated Staining Reagents Market and Forecast
5.2.7 Japan H&E Automated Staining Reagents Market - Company Share
5.3 Japan IVD Tissue Diagnostics (TDx) - Special Staining Market and Forecast
5.3.1 Japan Special Staining Market - Company Share
5.4 Japan IVD Tissue Diagnostics (TDx) - IHC Staining Market and Forecast
5.4.1 Japan IHC Staining Market - Company Share
5.4.2 Japan IVD Tissue Diagnostics (TDx) - Advanced Staining Instruments Market and Forecast
5.4.3 Japan Advanced Staining Instruments Market - Company Share
5.4.4 Japan IVD Advanced Staining - IHC Reagents Market and Forecast
5.5 Japan IVD Tissue Diagnostics (TDx) - ISH Staining Market and Forecast
5.5.1 Japan ISH Staining Market - Company Share
5.6 Japan IVD Tissue Diagnostics (TDx) - Digital Pathology Market and Forecast
5.6.1 Japan Digital Pathology Market - Company Share
5.7 Japan IVD Tissue Diagnostics (TDx) - Workflow Solutions Market and Forecast
5.7.1 Japan Workflow Solutions Market - Company Share

6. Japan IVD Tissue Diagnostics (TDx) Market - Company Profiles
6.1 Roche
6.2 Abbott Laboratories
6.3 Sakura Finetek Japan Co., Ltd.
6.4 Leica Biosystems
6.5 Agilent Dako
6.6 Nichirei Biosciences Inc.
6.7 Epredia

7. Japan IVD Market - Recent Developments
8. Japan In-vitro Diagnostics - Market Dynamics
8.1 Japan IVD Tissue Diagnostics (TDx) Market - Growth Drivers
8.2 Japan IVD Tissue Diagnostics (TDx) Market - Challenges

List of Figures:
Figure 3-1: Japan IVD - Tissue Diagnostics (TDx) Market (Million US$), 2021 -2024
Figure 3-2: Japan IVD - Forecast for Tissue Diagnostics (TDx) Market (Million US$), 2025 -2030
Figure 4-1: By Segment - Japan IVD Tissue Diagnostics (TDx) Market Share (Percent), 2021 -2024
Figure 4-2: By Segment - Forecast for Japan IVD Tissue Diagnostics (TDx) Market Share (Percent), 2025 -2030
Figure 5-1: Japan IVD Tissue Diagnostics (TDx) - Pre-Analytical Processing Market (Million US$), 2021 -2024
Figure 5-2: Japan IVD Tissue Diagnostics (TDx) - Forecast for Pre-Analytical Processing Market (Million US$), 2025 -2030
Figure 5-3: Japan Pre-Analytical Processing - Instruments Market (Million US$), 2021 -2024
Figure 5-4: Japan Pre-Analytical Processing - Forecast for Instruments Market (Million US$), 2025 -2030
Figure 5-5: Japan Pre-Analytical Processing - Consumables Market (Million US$), 2021 -2024
Figure 5-6: Japan Pre-Analytical Processing - Forecast for Consumables Market (Million US$), 2025 -2030
Figure 5-7: Japan Pre-Analytical Processing Market - Company Share (Percent), 2024
Figure 5-8: Japan IVD Tissue Diagnostics (TDx) - H&E Staining Market (Million US$), 2021 -2024
Figure 5-9: Japan IVD Tissue Diagnostics (TDx) - Forecast for H&E Staining Market (Million US$), 2025 -2030
Figure 5-10: Japan H&E Staining - Instruments Market (Million US$), 2021 -2024
Figure 5-11: Japan H&E Staining - Forecast for Instruments Market (Million US$), 2025 -2030
Figure 5-12: Japan H&E Staining Instruments Market - Company Share (Percent), 2024
Figure 5-13: Japan H&E Staining - Reagents Market (Million US$), 2021 -2024
Figure 5-14: Japan H&E Staining - Forecast for Reagents Market (Million US$), 2025 -2030
Figure 5-15: Japan H&E - Manual Staining Reagents Market (Million US$), 2021 -2024
Figure 5-16: Japan H&E- Forecast for Manual Staining Reagents Market (Million US$), 2025 -2030
Figure 5-17: Japan H&E Manual Staining Reagents Market - Company Share (Percent), 2024
Figure 5-18: Japan H&E - Automated Staining Reagents Market (Million US$), 2021 -2024
Figure 5-19: Japan H&E- Forecast for Automated Staining Reagents Market (Million US$), 2025 -2030
Figure 5-20: Japan H&E Automated Staining Reagents Market - Company Share (Percent), 2024
Figure 5-21: Japan IVD Tissue Diagnostics (TDx) - Special Staining Market (Million US$), 2021 -2024
Figure 5-22: Japan IVD Tissue Diagnostics (TDx) - Forecast for Special Staining Market (Million US$), 2025 -2030
Figure 5-23: Japan Special Staining Market - Company Share (Percent), 2024
Figure 5-24: Japan IVD Tissue Diagnostics (TDx) - IHC Staining Market (Million US$), 2021 -2024
Figure 5-25: Japan IVD Tissue Diagnostics (TDx) - Forecast for IHC Staining Market (Million US$), 2025 -2030
Figure 5-26: Japan IHC Staining Market - Company Share (Percent), 2024
Figure 5-27: Japan IVD Tissue Diagnostics (TDx) - Advanced Staining Instruments Market (Million US$), 2021 -2024
Figure 5-28: Japan IVD Tissue Diagnostics (TDx) - Forecast for Advanced Staining Instruments Market (Million US$), 2025 -2030
Figure 5-29: Japan Advanced Staining Instruments Market - Company Share (Percent), 2024
Figure 5-30: Japan IVD Advanced Staining - IHC Reagents Market (Million US$), 2021 -2024
Figure 5-31: Japan IVD Advanced Staining - Forecast for IHC Reagents Market (Million US$), 2025 -2030
Figure 5-32: Japan IVD Tissue Diagnostics (TDx) - ISH Staining Market (Million US$), 2021 -2024
Figure 5-33: Japan IVD Tissue Diagnostics (TDx) - Forecast for ISH Staining Market (Million US$), 2025 -2030
Figure 5-34: Japan ISH Staining Market - Company Share (Percent), 2024
Figure 5-35: Japan IVD Tissue Diagnostics (TDx) - Digital Pathology Market (Million US$), 2021 -2024
Figure 5-36: Japan IVD Tissue Diagnostics (TDx) - Forecast for Digital Pathology Market (Million US$), 2025 -2030
Figure 5-37: Japan Digital Pathology Market - Company Share (Percent), 2024
Figure 5-38: Japan IVD Tissue Diagnostics (TDx) - Workflow Solutions Market (Million US$), 2021 -2024
Figure 5-39: Japan IVD Tissue Diagnostics (TDx) - Forecast for Workflow Solutions Market (Million US$), 2025 -2030
Figure 5-40: Japan Workflow Solutions Market - Company Share (Percent), 2024

Companies Mentioned

  • Abbott Laboratories
  • Agilent Dako 
  • Epredia
  • Leica Biosystems 
  • Nichirei Biosciences Inc.
  • Roche 
  • Sakura Finetek Japan Co., Ltd.